Your session is about to expire
← Back to Search
PEA for Knee Osteoarthritis
Study Summary
This trial will study if a dietary supplement (PEA) can reduce pain in adults with knee osteoarthritis and determine how it works. It will look at protein signatures, inflammation markers & neurobiological pathways.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2018 Phase 2 trial • 17 Patients • NCT03066193Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have been diagnosed with osteoarthritis in one or both of your knees.You have used opioids in the last month.You are allergic to oat, coconut, citrus, olive, or sunflower oils, or maltodextrin.You have a type of arthritis called inflammatory arthritis, like rheumatoid arthritis.You have had a knee injury within the last 6 months.You have experienced knee pain that is consistently rated at least 4 out of 10 on a pain scale over the past month.You have advanced kidney disease, unstable angina (chest pain), congestive heart failure, or are currently being treated for cancer (except skin cancer).
- Group 1: palmitoylethanolamide (PEA)
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this trial accept elderly participants aged 85 and above?
"The scope of this clinical trial is exclusively reserved for patients aged 40 to 80; however, there are 38 additional studies available to those below 18 and 632 trials catering to individuals above 65."
Are there any open enrollment opportunities for this medical trial?
"Clinicaltrials.gov states that the clinical trial is presently recruiting participants. This research was posted on February 2nd, 2023 and modified on the same day."
How many people are participating in the experimentation of this clinical trial?
"Affirmatively, clinicaltrials.gov has the most recent information on this medical trial which was originally posted in February of 2023. The trial is actively recruiting and seeking out approximately 20 individuals at one site."
What are the prerequisites for taking part in this investigation?
"The current trial is looking for 20 adults aged between 40 and 80 who are English speaking, have self-reported diagnoses of osteoarthritis in one or both knees which cause at least 4/10 pain on a 0-10 numeric rating scale. In addition to agreeing to abstain from all other treatments (except acetaminophen as needed) participants must pass an evaluation to sign consent."
Share this study with friends
Copy Link
Messenger